Mammography | Sonomammogram | CESM | Combined | |
---|---|---|---|---|
False-negative lesions | 44 lesions | 28 lesions | 14 lesions | 3 lesions |
• Heterogeneous dense parenchyma | 27/44, 61.4% | 20/28, 71.5% | – | – |
• Single view asymmetries | 8/44, 18.2% | 1/28, 3.6% | – | – |
• Operative bed recurrence | 4/44, 9.1% | 2/28, 7.1% | – | – |
• Non-calcified DCIS | 3/44, 6.8% | 3/28, 10.7% | – | – |
• Bilateral asymmetries | 2/44, 4.5% | 2/28, 7.1% | – | – |
• Non-enhancing malignant lesions | – | – | 9/14, 64.3% | 2/3, 66.6% |
• Faintly enhancing lesions | – | – | 5/14, 35.7% | 1/3, 33.4% |
False-positive lesions | 66 lesions | 46 lesions | 30 lesions | 30 lesions |
• Heterogeneous dense breast | 23/66, 34.8% | 15/46, 32.6% | – | – |
• Inflammatory lesions | 21/66, 31.8% | 15/46, 32.6% | 17/30, 56.7% | 17/30, 56.7% |
• Benign masses | 11/66, 16.7% | 5/46. 10.9% | – | – |
• Benign precancerous lesions | 4/66, 6.1% | 4/46, 8.7% | 3/30, 10.0% | 3/30, 10.0% |
• Asymmetric breasts | 4/66, 6.1% | 4/46, 8.7% | – | – |
• Operative bed scarring | 3/66, 4.5% | 3/46, 6.5% | – | – |
• Benign enhancing lesions | – | – | 10/30, 33.3% | 10/30, 33.3% |